News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jerónimo Rafael Rodríguez Cid: A secondary analysis from MARIPOSA
Photo of Jerónimo Rafael Rodríguez Cid from Oncologia.mx
Jul 10, 2024, 09:39

Jerónimo Rafael Rodríguez Cid: A secondary analysis from MARIPOSA

Jerónimo Rafael Rodríguez Cid, Medical Oncologist at CDMX shared a post on X:

“We published this analysis of the Mariposa trial that shows the influence of p53 gene in patients with EGFR genetic alteration lung cancer treated with amivantamab versus osimertinib. We will never stop trying/Nunca dejaremos de intentarlo.”

Jerónimo Rafael Rodríguez

Read the article.

Source: Jerónimo Rafael Rodríguez Cid/X

cancer CDMX EGFR Jerónimo Rafael Rodríguez Cid Lung cancer OncoDaily Oncology p53 gene
Special Coverage
Opinion
Nov 13, 2024, 23:44
Peter Pisters: Honoring the veterans and active service members who have served our nation
Opinion
Nov 13, 2024, 23:39
Ajay Major: New consensus algorithm for the treatment of NLPHL by Graham Collins and Chan Cheah
Insight
Nov 13, 2024, 23:35
Raffaele Colombo: New BLA submitted for patients with EGFR-m NSCLC
Insight
Nov 13, 2024, 23:33
Closing the gap in lung cancer care - Color
Insight
Nov 13, 2024, 23:31
Researchers at the ICR have identified a promising treatment target for Acute Myeloid Leukaemia
Insight
Nov 13, 2024, 23:28
Danielle Bitterman: Looking forward to EMNLP2024
Insight
Nov 13, 2024, 23:26
Efficacy of subsequent therapies in advanced ovarian cancer
Insight
Nov 13, 2024, 23:24
Toufic Kachaamy: The yearly Phoenix walk to raise awareness for colorectal cancer
Insight
Nov 13, 2024, 23:22
Mireia Crispin on the emerging fields of application of AI tools
Career
Nov 13, 2024, 23:18
Elizabeth A. Mittendorf - Candidate for President Elect for ASCO
Insight
Nov 13, 2024, 19:27
Sexual dysfunction among childhood and adolescent Hodgkin lymphoma survivor - ACS Journal Cancer
Blog
Nov 13, 2024, 19:25
Culturally and Linguistically Appropriate Services in Nursing - Minority Health